Drugs.com - Pharma Industry News

Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB

THURSDAY, Feb. 6, 2025 -- Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, according to a study published in the Jan. 30 issue of the New...

Feb 9, 2025 - 21:45
 0
Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB
THURSDAY, Feb. 6, 2025 -- Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, according to a study published in the Jan. 30 issue of the New...
Read More

Tags:

Previous Article

HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia

Next Article

Prescriptions for Obesity Management Drugs Increasing

Related Posts

Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer

Nivolumab Added to Chemo Improves Response in ER+, HER2...

Feb 9, 2025  0

Screen Time Tied to Manic Symptoms in Preteens

Screen Time Tied to Manic Symptoms in Preteens

Feb 24, 2025  0

Early Childhood Stressful Life Events Linked to Increased Eczema Activity

Early Childhood Stressful Life Events Linked to Increas...

Feb 9, 2025  0